Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.7
agilon health, inc. updated its fiscal year 2023 guidance (reaffirmed).
- Period
- fiscal year 2023
- Guidance
- reaffirmed
- Result
- guidance update
Exact text from the filing
Outlook for Fiscal Year 2023: Year Ended December 31, 2023 Updated Guidance
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
agilon health, inc. reported the three and six months ended June 30, 2023 results: revenue $1.15 billion, net income Net loss of $17 million.
- Period
- the three and six months ended June 30, 2023
- Revenue
- $1.15 billion
- Net income
- Net loss of $17 million
- Result
- reported results
Exact text from the filing
agilon health Reports Second Quarter 2023 Results Revenue increased 71% to $1.15 billion, Medicare Advantage membership increased 57% to 408,900, and total members live on the agilon platform grew to 495,900
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
agilon health, inc. reported the second quarter ended June 30, 2023 results: revenue $1.15 billion, net income Net loss of $17 million. Guidance reaffirmed.
- Period
- the second quarter ended June 30, 2023
- Revenue
- $1.15 billion
- Net income
- Net loss of $17 million
- Guidance
- reaffirmed
- Result
- reported results
Exact text from the filing
except as shall be expressly set forth by specific reference therein. --- EX-99.1 (EX-99.1) --- agilon health Reports Second Quarter 2023 Results Revenue increased 71% to $1.15 billion, Medicare Advantage membership increased 57% to 408,900, and total members live on the agilon platform grew to 495,900 Durability of agilon partnership model driving continued
View on SEC.gov